US firm Johnson & Johnson has sought Emergency Use Authorisation (EUA) for its single-dose Covid-19 vaccine in India. J&J had withdrawn its application to the country's drug regulator as there is no requirement of local bridging trials, after the policy-tweak of fast-tracking foreign-produced Covid-19 vaccines.August 07, 2021 at 01:43AM
0 Comments